NEWS | BEAM Alliance

NEWS

Motif Bio Presents New Iclaprim Data at ECCMID 2019

Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that new iclaprim data are being presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019) in Amsterdam, The Netherlands.

Full PR available here